Medical technology company BD (Becton, Dickinson and Company) announced Monday that it has acquired Irish biotechnology company GenCell Biosystems. Read More »»
Regado Bioscience Inc., a Basking Ridge-based biopharmaceutical company, announced Friday that it has appointed Michael A. Metzger, the current president of Regado, to the additional duty of chief executive officer and member of its board of directors, effective immediately. Read More »»
Cranbury-based cancer-drug company Cornerstone Pharmaceuticals announced Thursday that it has named Steve Carchedi chief executive officer and a member of the board of directors. Read More »»
The parent company of Middlesex-based pharmaceutical firm CorePharma LLC will be sold to a California-based specialty drugmaker as part of a $700 million deal. Read More »»
Health care company Allergan issued a WARN notice to workers this week, saying 69 jobs in Bridgewater would be affected as of Nov. 28. Read More »»
Teaneck-based Cognizant announced Tuesday its acquisition of Pennsylvania-based digital marketing agency Cadient Group. Read More »»
Investment in New Jersey's biopharma companies more than doubled in 2013, as a spike in initial public offerings helped the industry attract more than $900 million in total funding. Read More »»
WIRB-Copernicus Group, a Princeton-based provider of regulatory and ethical review services and software for clinical research, said Thursday that Dr. Lindsay McNair has been promoted to its chief medical officer. Read More »»
Madison-based Quest Diagnostics unveiled its new state-of-the-art, 200,000-square-foot “lab of the future” Thursday to much fanfare — and the promise of 1,350 new jobs. Read More »»
Merck announced Wednesday that it has completed the previously announced, $14.2 billion sale of its consumer care business to Bayer AG. Read More »»
IGI Laboratories, Inc., a Buena-based generic drugmaker, announced Wednesday that it has acquired two ophthalmic drugs from Valeant Pharmaceuticals International, Inc., affiliates. Read More »»
Valeant Pharmaceuticals International, Inc., said Tuesday that its Bridgewater location received a warning letter from the U.S. Food and Drug Administration tied to a records inspection conducted in June. Read More »»
Aerie Pharmaceuticals, Inc., which has corporate offices in Bedminster, said Tuesday that it has closed on $125 million in financing. Read More »»
BioNJ released its study of the biomedical industry for the calendar year of 2013 on Sept. 29. Conducted by the industry group in conjunction with EY (formerly known as Ernst & Young), the study serves as a “state of the union” report on the biomedical industry in New Jersey. Read More »»
DPx Holdings B.V., a North Carolina pharmaceutical company, announced Tuesday that it has completed its acquisition of Gallus BioPharmaceuticals, LLC, a St. Louis biologic manufacturing company with facilities in Princeton. Read More »»
Johnson & Johnson on Tuesday announced it has a definitive agreement to purchase biopharmaceutical company Alios BioPharma, Inc., for approximately $1.75 billion in cash. Read More »»
IGI Laboratories Inc., a Buena-based generic drugmaker, announced Thursday that it has acquired the regulatory rights to 18 drug products from AstraZeneca. Read More »»
Bridgewater-based generic drugmaker Amneal Pharmaceuticals LLC announced Tuesday that it has signed a lease to expand its national sales and distribution center in Kentucky. Read More »»
Pharmaceutical giant Bristol-Myers Squibb announced Tuesday that it plans to build a 650,000-square-foot office building in Lawrenceville near the intersection of Interstate 295 and the Princeton Pike on company-owned property acquired back in 2001. Read More »»
Denise Morrison — president and CEO of Campbell Soup Company...
In March 2012, I was delighted when Comcast Corporation Chairman and CEO, Brian...
“I used to be cool,” says the aging Budweiser brand at nearly 139...
A study published Wednesday by the Human Rights Campaign scores companies...